Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kerendia
Pharma
In push to boost Kerendia, Bayer adds 3 heart failure trials
Bayer plans three new trials to assess Kerendia in heart failure. The drug was first approved 2 years ago in CKD associated with diabetes.
Kevin Dunleavy
Sep 1, 2023 11:03am
Bayer's new CEO Bill Anderson weighs structural change
Aug 8, 2023 11:15am
Bayer's potential blockbusters Nubeqa, Kerendia thrive in Q1
May 11, 2023 11:16am
Bayer survey finds flaws in kidney disease comms, diagnosis
Mar 14, 2023 8:05am
Bayer sees Eylea slowdown continuing in '23
Feb 28, 2023 11:43am
Bayer projects $3B sales potential each for Kerendia, Nubeqa
Jan 10, 2023 4:20pm